In 2024, cybersecurity venture investments surged 43% to nearly $11.6 billion, driven by significant rounds despite flat funding in Q4 and fewer overall deals. Notable mega-deals included Wiz’s $1 billion funding round. However, the number of deals dropped sharply, raising concerns about the sustainability of funding and the impact on numerous startups as investors increasingly … Read more
Isomorphic Labs, Google’s A.I. drug division, has raised $600 million, led by Thrive Capital. This funding highlights their advancements in drug design using A.I., particularly with technologies like AlphaFold, which accelerates drug development. The company aims to transform the drug discovery process through computerization. Isomorphic Labs, Google’s ambitious A.I. drug division, has secured an impressive … Read more
In the latest funding wave, OpenAI leads with a historic $6.6 billion round, supported by notable investors like Thrive Capital and Microsoft. Poolside raises $500 million while Kailera Therapeutics garners $400 million in biotech funding. Overall, several companies exceeded $100 million, underscoring a robust investment climate in AI and biotech despite challenges. In a notable … Read more